Investigation of a series of silver-N-Heterocyclic carbenes as antibacterial agents: Activity, synergistic effects, and cytotoxicity

Chemistry - A European Journal

Volumn 17, Issue 5, 2011, Pages 1442-1446

  Roland, Sylvain ^a   Jolivalt, Claude ^b   Cresteil, Thierry ^c   Eloy, Laure ^c   Bouhours, Pascale ^b   Hequet, Arnaud ^b   Mansuy, Virginie ^a   Vanucci, Corinne ^a   Paris, Jean Marc ^b  

^a Université Pierre et Marie Curie   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

antibiotics; carbene ligands; cytotoxicity; silver; synergy

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL AGENT; CARBENE LIGANDS; CIPROFLOXACIN; LOW CONCENTRATIONS; N-HETEROCYCLIC CARBENES; PUBLIC HEALTH; RESISTANT STRAINS; S. AUREUS; SYNERGISTIC EFFECT; SYNERGY;

ANTIBIOTICS; CARBON INORGANIC COMPOUNDS; CYTOTOXICITY; ORGANIC COMPOUNDS; SILVER;

LIGANDS;

ANTIINFECTIVE AGENT; CARBENE; DRUG DERIVATIVE; HETEROCYCLIC COMPOUND; LIGAND; METHANE; SILVER DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY;

ANTI-BACTERIAL AGENTS; HETEROCYCLIC COMPOUNDS; LIGANDS; METHANE; MOLECULAR STRUCTURE; SILVER COMPOUNDS;

EID: 79251604711     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201002812     Document Type: Article

References (43)

1. D. Bourissou, O. Guerret, F. P. Gabbai, G. Bertrand, Chem. Rev. 2000, 100, 39-91
2. W. A. Herrmann, Angew. Chem. 2002, 114, 1342-1363
3. Angew. Chem. Int. Ed. 2002, 41, 1290-1309
4. F. E. Hahn, M. C. Jahnke, Angew. Chem. 2008, 120, 3166-3216
5. Angew. Chem. Int. Ed. 2008, 47, 3122-3172
6. S. Díez-González, N. Marion, S. P. Nolan, Chem. Rev. 2009, 109, 3612-3676.
7. K. M. Hindi, M. J. Panzner, C. A. Tessier, C. L. Cannon, W. J. Youngs, Chem. Rev. 2009, 109, 3859-3884
8. M. L. Teyssot, A. S. Jarrousse, M. Manin, A. Chevry, S. Roche, F. Norre, C. Beaudoin, L. Morel, D. Boyer, R. Mahiou, A. Gautier, Dalton Trans. 2009, 6894-6902
9. H. G. Raubenheimer and S. Cronje, Chem. Soc. Rev. 2008, 37, 1998-2011
10. P. J. Barnard, S. J. Berners-Price, Coord. Chem. Rev. 2007, 251, 1889-1902
11. A. Kascatan-Nebioglu, M. J. Panzner, C. A. Tessier, C. L. Cannon, W. J. Youngs, Coord. Chem. Rev. 2007, 251, 884-895.
12. B. Çetinkaya, E. Çetinkaya, H. Kucukbay, R. Durmaz, Arzneim.-Forsch. 1996, 46, 821-823
13. B. Çetinkaya, I. Ozdemir, B. Binbasioglu, R. Durmaz, S. Gunal, Arzneim.-Forsch. 1999, 49, 538-540
14. I. Ozdemir, A. Denizci, H. T. Ozturk, B. Çetinkaya, Appl. Organomet. Chem. 2004, 18, 318-322
15. A. Melaiye, R. S. Simons, A. Milsted, F. Pingitore, C. Wesdemiotis, C. A. Tessier, W. J. Youngs, J. Med. Chem. 2004, 47, 973-977
16. J. C. Garrison, C. A. Tessier, W. J. Youngs, J. Organomet. Chem. 2005, 690, 6008-6020
17. A. Melaiye, Z. H. Sun, K. Hindi, A. Milsted, D. Ely, D. H. Reneker, C. A. Tessier, W. J. Youngs, J. Am. Chem. Soc. 2005, 127, 2285-2291
18. A. Kascatan-Nebioglu, A. Melaiye, K. Hindi, S. Durmus, M. J. Panzner, L. A. Hogue, R. J. Mallett, C. E. Hovis, M. Coughenour, S. D. Crosby, A. Milsted, D. L. Ely, C. A. Tessier, C. L. Cannon, W. J. Youngs, J. Med. Chem. 2006, 49, 6811-6818
19. K. M. Hindi, T. J. Siciliano, S. Durmus, M. J. Panzner, D. A. Medvetz, D. V. Reddy, L. A. Hogue, C. E. Hovis, J. K. Hilliard, R. J. Mallet, C. A. Tessier, C. L. Cannon, W. J. Youngs, J. Med. Chem. 2008, 51, 1577-1583
20. M. J. Panzner, A. Deeraksa, A. Smith, B. D. Wright, K. M. Hindi, A. Kascatan-Nebioglu, A. G. Torres, B. M. Judy, C. E. Hovis, J. K. Hilliard, R. J. Mallett, E. Cope, D. M. Estes, C. L. Cannon, J. G. Leid, W. J. Youngs, Eur. J. Inorg. Chem. 2009, 1739-1745
21. M. J. Panzner, K. M. Hindi, B. D. Wright, J. B. Taylor, D. S. Han, W. J. Youngs, C. L. Cannon, Dalton Trans. 2009, 7308-7313
22. C. L. Cannon, L. A. Hogue, R. K. Vajravelu, G. H. Capps, A. Ibricevic, K. M. Hindi, A. Kascatan-Nebioglu, M. J. Walter, S. L. Brody, W. J. Youngs, Antimicrob. Agents Chemother. 2009, 53, 3285-3293
23. S. Ray, R. Mohan, J. K. Singh, M. K. Samantaray, M. M. Shaikh, D. Panda, P. Ghosh, J. Am. Chem. Soc. 2007, 129, 15042-15053.
24. The MIC is defined as the lowest concentration of an antimicrobial that visibly inhibits bacterial growth.
25. S. B. Levy, B. Marshall, Nat. Med. 2004, 10, S 122 -S 129.
26. B. S. Atiyeh, M. Costagliola, S. N. Hayek, S. A. Dibo, Burns 2007, 33, 139-148.
27. V. K. M. Poon, A. Burd, Burns 2004, 30, 140-147
28. R. White, K. Cutting, Wounds 2006, 18, 307-314.
29. J. C. Garrison, W. J. Youngs, Chem. Rev. 2005, 105, 3978-4008
30. I. J. B. Lin, C. S. Vasam, Coord. Chem. Rev. 2007, 251, 642-670.
31. See the Supporting Information for details.
32. H. M. J. Wang, I. J. B. Lin, Organometallics 1998, 17, 972-975.
33. G. W. Kaatz, S. M. Seo, Antimicrob. Agents Chemother. 1995, 39, 2650-2655.
34. J. I. Ross, E. A. Eady, J. H. Cove, W. J. Cundliffe, S. Baumberg, Mol. Microbiol. 1990, 4, 1207-1214.
35. B. Marquez, L. Neuville, N. J. Moreau, J.-P. Genet, A. F. dos Santos, M. C. Caño dea Andrade, A. E. G. Sant'Ana, Phytochemistry 2005, 66, 1804-1811.
36. Imidazoli(ni)um salts possessing significant antimicrobial activities have been reported in the literature, see ref.a [2a].
37. R. Chait, A. Craney, R. Kishony, Nature 2007, 446, 668-671.
38. A. Mohammeda Fayaz, K. Balaji, M. Girilal, R. Yadav, P. T. Kalaichelvan, R. Venketesan, Nanomed. Nanotechnol. Biol. Med. 2010, 6, 103-109
39. P. Li, J. Li, C. Wu, Q. Wu, J. Li, Nanotechnology 2005, 16, 1912-1917.
40. S. Loewe, Arzneim.-Forsch. 1953, 3, 285-290.
41. L. Zhang, S. Ma, ChemMedChem 2010, 5, 477.
42. E. Hidalgo, R. Bartolomé, C. Barroso, A. Moreno, C. Dominguez, Skin Pharmacol. App. Skin 1998, 11, 140-151.
43. 50 on human cells has to be at least two orders of magnitude higher than the MIC against bacteria for a compound to be further developed as a potential oral antibiotic.